Larimar Therapeutics Inc. Employee Directory
Biotechnology ResearchPennsylvania, United States51-200 Employees
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Based in Bala Cynwyd, Pennsylvania, the company is advancing its lead candidate, CTI-1601, in a Phase 1 program aimed at Friedreich's ataxia. Beyond CTI-1601, Larimar intends to leverage its intracellular delivery platform to design additional fusion proteins targeting other rare diseases characterized by deficiencies in intracellular bioactive compounds. The firm operates within the biotechnology research sector and concentrates its efforts on therapies for rare genetic conditions. Its work addresses unmet medical needs for Friedreich's ataxia and related diseases. In January 2026, Larimar participated in the 44th Annual J.P. Morgan Healthcare Conference, conducting investor meetings to discuss its programs.